Mark R Sotir Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark R Sotir.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark R Sotir. Mark R Sotir is Director in Adams Respiratory Therapeutics, Inc. ($ARXT) and Director in Archrock, Inc. ($EXH) and Executive Chairman in Exterran Corp ($EXTN).
Latest Insider Trading Transactions of Mark R Sotir
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARXT, EXH, EXTN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2021 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 4.84 | 6,280 | 30,395 | 119,808 | 113.5 K to 119.8 K (+5.53 %) |
| Mar 08 2021 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 4.84 | 25,827 | 125,003 | 113,528 | 87.7 K to 113.5 K (+29.45 %) |
| Aug 13 2020 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 5.94 | 5,419 | 32,189 | 80,288 | 74.9 K to 80.3 K (+7.24 %) |
| Mar 06 2020 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 7.27 | 17,194 | 125,000 | 74,869 | 57.7 K to 74.9 K (+29.81 %) |
| Mar 04 2020 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 7.20 | 4,470 | 32,184 | 57,675 | 53.2 K to 57.7 K (+8.40 %) |
| Nov 08 2019 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 9.44 | 3,409 | 32,181 | 53,205 | 49.8 K to 53.2 K (+6.85 %) |
| Aug 12 2019 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 10.62 | 3,030 | 32,179 | 49,796 | 46.8 K to 49.8 K (+6.48 %) |
| Nov 09 2018 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 22.77 | 1,405 | 31,992 | 37,518 | 36.1 K to 37.5 K (+3.89 %) |
| Aug 10 2018 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 27.78 | 1,178 | 32,725 | 36,113 | 34.9 K to 36.1 K (+3.37 %) |
| Mar 06 2018 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 26.24 | 4,764 | 125,007 | 34,935 | 30.2 K to 34.9 K (+15.79 %) |
| Mar 06 2018 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 26.24 | 1,129 | 29,625 | 30,171 | 29 K to 30.2 K (+3.89 %) |
| Nov 13 2017 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 32.44 | 890 | 28,872 | 29,042 | 28.2 K to 29 K (+3.16 %) |
| Aug 11 2017 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 26.08 | 1,107 | 28,871 | 28,152 | 27 K to 28.2 K (+4.09 %) |
| Mar 16 2017 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 0.00 | 1,172 | 0 | 27,045 | 25.9 K to 27 K (+4.53 %) |
| Mar 07 2017 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 0.00 | 3,645 | 0 | 25,873 | 22.2 K to 25.9 K (+16.40 %) |
| Jan 10 2017 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 27.55 | 2,422 | 66,726 | 22,228 | 19.8 K to 22.2 K (+12.23 %) |
| Mar 08 2016 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 0.00 | 7,277 | 0 | 19,806 | 12.5 K to 19.8 K (+58.08 %) |
| Nov 05 2015 | EXTN | Exterran Corp | Sotir Mark R | Executive Chairman | Grant | A | 0.00 | 12,529 | 0 | 12,529 | 0 to 12.5 K |
| Mar 05 2015 | EXH | Archrock, Inc. | Sotir Mark R | Director | Grant | A | 0.00 | 3,915 | 0 | 25,059 | 21.1 K to 25.1 K (+18.52 %) |
| Jan 30 2008 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Option Exercise | D | 59.86 | 4,000 | 239,440 | 0 | |
| Jan 30 2008 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Option Exercise | D | 37.53 | 8,000 | 300,240 | 0 | |
| Jan 30 2008 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Sell | D | 60.00 | 1,072 | 64,320 | 0 | 1.1 K to 0 (-100.00 %) |
| Jan 03 2008 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Grant | A | 0.00 | 210 | 0 | 1,072 | 862 to 1.1 K (+24.36 %) |
| Dec 18 2007 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Option Exercise | A | 59.86 | 4,000 | 239,440 | 4,000 | |
| Oct 03 2007 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Grant | A | 0.00 | 323 | 0 | 862 | 539 to 862 (+59.93 %) |
| Jul 05 2007 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Grant | A | 0.00 | 316 | 0 | 539 | 223 to 539 (+141.70 %) |
| Apr 23 2007 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Option Exercise | A | 37.53 | 8,000 | 300,240 | 8,000 | |
| Apr 23 2007 | ARXT | Adams Respiratory ... | Sotir Mark R | Director | Grant | A | 0.00 | 223 | 0 | 223 | 0 to 223 |
Page: 1